Analyst Bryan Bergin of TD Cowen reiterated a Buy rating on Genpact, retaining the price target of $56.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bryan Bergin has given his Buy rating due to a combination of factors that highlight Genpact’s strong performance and strategic positioning. The company demonstrated solid revenue growth in the second quarter, surpassing expectations in both revenue and earnings per share. This was driven by robust growth in its Digital Transformation and Intelligent Automation (DTAI) and Advanced Technology Solutions (ATS) segments, alongside steady performance in Digital Operations and Consumer Business Services (CBS). The improvement in deal flow and the successful closure of significant contracts further bolster the company’s outlook.
Bergin also notes that Genpact’s execution has put it back on track after a challenging first quarter, with the company maintaining a prudent outlook for the second half of the year. The company’s ability to outperform its guidance and the strong pipeline of deals, particularly in the data and AI space, supports the upward momentum in its share price. Additionally, the development of high-value agentic solutions and the expansion of Genpact’s GenAI offerings are contributing to its growth, making it well-positioned to achieve its medium-term targets. These factors collectively underpin Bergin’s confidence in the stock, leading to a reiterated Buy rating and a price target of $56.
In another report released on August 6, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $47.00 price target.
Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of G in relation to earlier this year.